A Semaine Health education guide on why urinary tract infections become more common in perimenopause and beyond, and what actually helps. Sources linked throughout.
The short answer
If urinary tract infections became a recurring problem around perimenopause, even if they never were before, there is a hormonal reason. As estrogen declines, it changes the tissue and the microbial balance of the urinary and vaginal environment, removing defenses that previously kept bacteria like E. coli in check. The urinary microbiome itself shifts with menopausal status. The result: UTIs become more frequent with age, and recurrence climbs. It is not random, and it is not your fault. It is a predictable consequence of the hormonal transition, which means it can be supported intelligently.
Does UTI risk really increase with age?
Yes. Urinary concerns are common across adult life, with a lifetime incidence in women of 50 to 60%, but prevalence roughly doubles in women over 65 (Medina & Castillo-Pino, 2019, Ther Adv Urol). In very old women, nearly 30% had a UTI in a single year, and 60% over five years (Eriksson et al., 2009, Arch Gerontol Geriatr). Urinary tract concerns and urinary incontinence also travel together in postmenopausal women (Moore et al., 2008, Obstet Gynecol). So the lived experience, "this started in my forties and won't stop," is exactly what the population data shows.
Why is estrogen the hidden variable?
Estrogen does quiet, essential maintenance work on the urinary and vaginal environment. It supports the tissue integrity of the urinary tract and helps maintain the protective microbial balance: the acidic, Lactobacillus-friendly environment that suppresses pathogenic E. coli. As estrogen declines through perimenopause and after, that environment changes. The tissue changes, the protective acidity changes, and the conditions that used to keep bacteria in check become more hospitable to them.
This isn't hand-waving. The urinary microbiome (yes, urine has its own community of bacteria) has been shown to shift depending on menopausal status, and that shift is linked to how recurrent urinary concerns and related bladder conditions play out in post-menopausal women (Bhide, Tailor & Khullar, 2020, Post Reprod Health). Post-menopausal urinary shifts have a hormonal cause. The biology is explainable, it's just rarely explained to the women living it.
Why does this matter for how you respond?
Two implications follow from the biology.
First, the urinary issue and the hormonal transition are connected, so they're worth addressing together. Treating each new UTI in isolation ignores the environment that's making them more likely. (Semaine's perspective: support the hormonal transition and the urinary environment the transition is disrupting.)
Second, antibiotics alone don't address the changed environment. They clear an active infection but don't restore the conditions that changed, and repeated courses carry their own costs: resistance, and disruption of the gut and vaginal microbiota that help protect you (Foxman, 2010, Nat Rev Urol). This is why clinical guidelines increasingly emphasize non-antibiotic prevention for recurrent UTIs (Anger et al., 2019, AUA/CUA/SUFU Guideline; Sihra et al., 2018, Nat Rev Urol).
What helps support the urinary environment?
For postmenopausal women, vaginal estrogen is the strongest non-cranberry option. Because declining estrogen is the root driver, restoring it locally to the urogenital tissue directly addresses the cause. Vaginal estrogen reduces recurrent UTIs in postmenopausal women and is endorsed in current urology guidance (Buck & Rubin, 2020, Urology; Anger et al., 2019). It is a prescription option, so discuss it with your clinician.
For the urinary environment specifically, standardized cranberry, in a form that actually absorbs, has the supplement evidence. The largest review to date found cranberry products reduced UTI risk overall and in women with recurrent UTIs (Williams et al., 2023, Cochrane Database Syst Rev). Cranberry's PACs reduce uropathogenic E. coli adhesion, and in clinical research using cranberry phytosome, the form that survives digestion and reaches urine, it modulated urinary tract episodes in postmenopausal women at elevated risk (Rondanelli et al., 2024, Nutrients). (For why the form of cranberry decides whether it works, see our evidence guide and the full comparison of options.) Because the goal is to support an environment rather than react to an episode, it's daily practice, not a once-in-a-while fix.
How Semaine approaches this
Two products address the two halves of this picture. Urinary Tract Cleanse & Protect (Anthocran® Phytosome® + standardized hibiscus) supports the urinary environment that the hormonal shift disrupts. Hormone Balance and Semaine's menopause support address the hormonal transition itself. Menopause support for the shift; urinary support for the environment the shift changes. Both are daily investments in your biology, not quick fixes.
Frequently asked questions
Why am I suddenly getting UTIs in perimenopause?
Declining estrogen changes the tissue and microbial balance of the urinary and vaginal environment, removing defenses that kept bacteria in check; the urinary microbiome also shifts with menopausal status (Bhide et al., 2020).
Do UTIs get more common after menopause?
Yes. Lifetime incidence in women is 50 to 60%, and prevalence roughly doubles after 65 (Medina & Castillo-Pino, 2019); nearly 30% of very old women had a UTI in a single year (Eriksson et al., 2009).
Can supporting hormones help with urinary issues?
The hormonal transition and the urinary environment are biologically linked, so they're worth addressing together. Clinical guidelines emphasize non-antibiotic prevention for recurrent UTIs, and for postmenopausal women, vaginal estrogen reduces recurrence (Anger et al., 2019; Buck & Rubin, 2020). Discuss options, including vaginal estrogen, with your clinician.
What can I do besides antibiotics?
For postmenopausal women, vaginal estrogen has the strongest evidence and addresses the root cause (Buck & Rubin, 2020). Reviews of non-antibiotic prevention cover several other options (Sihra et al., 2018); for the urinary environment, standardized cranberry has positive evidence overall (Williams 2023), and cranberry phytosome has clinical support in postmenopausal women at elevated risk (Rondanelli et al., 2024).
Educational content; not medical advice. See a clinician for an active infection or to discuss hormonal options. Sources peer-reviewed and indexed on PubMed.
